# ClinicoPath News

## Version 0.0.31.03

### ‚ö° **Enhanced Competing Risks Analysis - Advanced Implementation**

#### üî¨ **Advanced Competing Risks Features (competingsurvival)**
*   **Risk Stratification for Competing Events:** Quantile-based approach for categorizing patients into Low/Moderate/High risk groups based on competing event probabilities
*   **Time-Dependent Cumulative Incidence Analysis:** Interval-based event rate tracking with comprehensive time-point analysis throughout follow-up period
*   **Enhanced Summary Reporting:** Advanced clinical interpretation with detailed feature descriptions and predictive capabilities
*   **Comprehensive Integration:** Seamless integration with existing Fine-Gray subdistribution hazard models and Gray's test functionality
*   **Clinical Impact:** Provides advanced risk stratification tools essential for competing risks clinical decision-making and patient prognosis assessment
*   **Target Applications:** Oncology outcomes with competing mortality risks, geriatric populations with multiple morbidities, cardiovascular disease progression studies

### ü§ñ **Machine Learning Enhanced Survival Analysis - Comprehensive Implementation**

#### üéØ **Advanced ML Features for Multivariable Survival (multisurvival)**
*   **Random Forest Survival Analysis:** Complete randomForestSRC integration with variable importance calculation, out-of-bag error estimation, and prediction intervals
*   **Regularized Cox Regression:** Cross-validated LASSO/Ridge/Elastic Net using glmnet with automatic lambda selection and feature selection capabilities
*   **Ensemble Methods:** Multi-model approach combining Random Forest + Cox + glmnet with customizable weighting strategies (equal, optimized, user-defined)
*   **Cross-Validated Feature Selection:** Bootstrap-based stability selection with frequency analysis and automated variable importance ranking
*   **Advanced Performance Metrics:** Concordance index calculation, deviance explained, out-of-bag error rates, and cross-validation performance summaries
*   **Prediction Intervals:** Model-specific risk predictions with confidence intervals and automatic risk group stratification
*   **Non-Breaking Integration:** ML features only activate when explicitly selected (ml_method != 'cox'), preserving all existing Cox regression functionality
*   **Graceful Degradation:** Automatic fallback to standard analysis if ML packages unavailable, with informative user guidance
*   **Clinical Impact:** Advanced predictive modeling for survival analysis enabling robust feature selection, ensemble predictions, and uncertainty quantification for precision medicine applications
*   **Target Applications:** High-dimensional biomarker studies, multi-omics survival analysis, personalized risk prediction, clinical decision support systems

### üìä **Parametric Survival Models - Advanced Implementation**

#### üî¨ **Comprehensive Parametric Modeling for Univariate Survival (survival)**
*   **Flexible Distribution Support:** Complete implementation of exponential, Weibull, log-normal, log-logistic, gamma, generalized gamma, Gompertz, and Royston-Parmar spline distributions
*   **Spline-based Hazard Functions:** Advanced flexible parametric models using Royston-Parmar splines with customizable knots (1-10) and scale options (hazard, odds, normal)
*   **Automated Model Comparison:** AIC/BIC-based distribution selection with comprehensive model diagnostics and goodness-of-fit statistics
*   **Covariate Integration:** Full support for explanatory variables in parametric models, extending beyond Cox regression assumptions
*   **Survival Extrapolation:** Advanced extrapolation capabilities beyond observed follow-up time for health economic modeling and long-term prognosis
*   **Hazard Function Visualization:** Direct hazard rate plotting showing how instantaneous risk changes over time for different parametric distributions
*   **Model Diagnostics Suite:** Comprehensive diagnostics including parameter estimates, confidence intervals, model fit statistics, and clinical interpretation
*   **Kaplan-Meier Comparison:** Visual validation of parametric models against non-parametric Kaplan-Meier estimates
*   **Clinical Impact:** Enables explicit survival function specification, extrapolation for economic evaluations, and alternative to Cox regression when parametric assumptions are met
*   **Target Applications:** Health technology assessments, pharmaco-economic modeling, clinical trial design, regulatory submissions, long-term survival projections
*   **Integration:** Seamless integration with existing survival analysis workflow, backward compatibility with all current features

### üöÄ Digital Pathology Statistical Methods - Comprehensive Module Suite

*   **Advanced Statistical Analysis Framework:** Implementation of 7 critical statistical modules addressing major gaps in digital pathology research methodology

#### üî¨ **Enhanced Non-Parametric Tests Module (enhancednonparametric)**
*   **Enhanced Mann-Whitney U Test:** Complete implementation with rank-biserial correlation effect size, exact test options, confidence intervals for location shift
*   **Advanced Kruskal-Wallis Test:** Comprehensive multi-group comparisons with eta-squared and epsilon-squared effect sizes
*   **Dunn's Post Hoc Analysis:** Proper post hoc testing with multiple comparison corrections (Bonferroni, Holm, FDR, Benjamini-Hochberg)
*   **Effect Size Suite:** Rank-biserial correlation, Cliff's Delta, eta-squared, epsilon-squared with clinical interpretation guidelines
*   **Assumption Checking:** Automated normality testing (Shapiro-Wilk), homogeneity of variance (Levene's test), recommendations for test selection
*   **Clinical Impact:** Addresses critical gap where ~30% of pathology studies use non-parametric tests but fail to report proper effect sizes
*   **Target Packages:** Built-in R + `dunn.test`, `car` for comprehensive non-parametric analysis
*   **Applications:** Biomarker expression comparisons, tumor grade analysis, immunohistochemical scoring, digital pathology metrics

#### üî¨ **Advanced ANOVA Suite Module (advancedanova)**
*   **Comprehensive Post Hoc Testing:** Complete implementation of Tukey HSD, Games-Howell (unequal variances), Dunnett's test (control comparisons), Bonferroni and Holm corrections
*   **Enhanced ANOVA Diagnostics:** Comprehensive assumption checking (normality, homogeneity), effect sizes (eta-squared, omega-squared, Cohen's f), Welch correction and robust ANOVA options
*   **Clinical Impact:** Addresses the critical issue where 68% of pathology studies fail to perform proper multiple comparisons
*   **Target Packages:** Built-in R + `multcomp`, `emmeans`, `car`
*   **Applications:** Multi-group biomarker comparisons, tumor grade/stage analysis, treatment group efficacy studies

#### üè• **Hierarchical Mixed-Effects Models Module (hierarchicalpathology)**
*   **Three-Level Hierarchical Models:** Complete support for Patient > Slide > ROI > Cell nested structure with random effects for multiple clustering levels
*   **Variance Component Analysis:** Intraclass Correlation Coefficient (ICC) calculation and variance partition across hierarchical levels
*   **Generalized Linear Mixed Models:** Linear, logistic, Poisson, and negative binomial mixed models for diverse outcome types
*   **Clinical Impact:** Essential for proper WSI (Whole Slide Image) analysis and multi-ROI studies, prevents Type I errors from ignoring clustering
*   **Target Packages:** `lme4`, `nlme`, `performance`, `glmmTMB`
*   **Applications:** Digital pathology multi-ROI analysis, nested data structure modeling

#### üìä **Optimal Cutpoint Determination Module (optimalcutpoint)**
*   **Maximally Selected Rank Statistics:** Optimal cutpoint determination for continuous biomarkers with log-rank test optimization for survival analysis
*   **Concordance Index Optimization:** C-index based cutpoint selection with bootstrap validation and cross-validation for robust estimation
*   **Comprehensive Cutpoint Methods:** Youden Index maximization, closest to top-left corner optimization, ROC01 cost minimization, time-dependent ROC analysis
*   **Clinical Impact:** Essential for converting continuous biomarkers to clinical thresholds, prevents arbitrary cutpoint selection
*   **Target Packages:** `survminer`, `maxstat`, `OptimalCutpoints`, `cutpointr`
*   **Applications:** Biomarker threshold development, diagnostic test optimization, pathology scoring systems

#### üìà **Enhanced Chi-Square and Fisher's Tests Module (categoricaladvanced)**
*   **Enhanced Chi-Square Testing:** Effect sizes (Cram√©r's V, phi coefficient, Cohen's w), standardized residual analysis, post hoc pairwise comparisons
*   **Advanced Fisher's Exact Tests:** Stratified Fisher's exact tests, exact confidence intervals for odds ratios, mid-p exact tests, Freeman-Halton extension for r√óc tables
*   **Categorical Association Measures:** Lambda, Tau, and Gamma measures with comprehensive effect size reporting and confidence intervals
*   **Clinical Impact:** Addresses the 25% error rate in categorical analysis within pathology studies
*   **Target Packages:** Built-in R + `DescTools`, `vcd`, `chisq.posthoc.test`
*   **Applications:** Biomarker positivity analysis, tumor grade associations, diagnostic test performance

#### üß¨ **Diagnostic Test Meta-Analysis Module (diagnosticmeta)**
*   **Bivariate Random-Effects Models:** Complete implementation for sensitivity/specificity meta-analysis with HSROC curves
*   **Meta-Regression Analysis:** Heterogeneity source identification with comprehensive publication bias assessment using Deeks' funnel plot test
*   **Advanced Visualization:** Forest plots for sensitivity/specificity, summary ROC plots with confidence regions
*   **Clinical Impact:** AI algorithm performance meta-analysis, biomarker diagnostic accuracy synthesis for clinical implementation
*   **Target Packages:** `mada`, `meta`, `metafor`
*   **Applications:** Systematic reviews, evidence synthesis, diagnostic accuracy studies

#### ü§ñ **Classification Performance Metrics Module (mlpathology)**
*   **ML Performance Evaluation:** Comprehensive confusion matrix metrics, ROC analysis with DeLong's test for curve comparison
*   **Advanced Comparison Methods:** McNemar's test for paired classifier comparison with bootstrap confidence intervals
*   **Segmentation Metrics:** Dice coefficient, Jaccard index, Hausdorff distance for computer vision validation
*   **Clinical Impact:** Statistical validation framework for AI deployment in clinical practice
*   **Target Packages:** `pROC`, `caret`, `MLmetrics`
*   **Applications:** AI model validation, algorithm comparison studies, segmentation quality assessment

#### üî¨ **Pathology Composition Analysis Module (pathologycomposition)**
*   **Semi-Quantitative Component Analysis:** Five-category system (absent, ‚â§10%, >10%-‚â§50%, >50%-<90%, ‚â•90%) based on gastric cancer research methodology
*   **Multi-Component Risk Analysis:** Individual component risk assessment with logistic regression and multi-component probability calculations
*   **Optimal Composition Patterns:** Risk threshold analysis for clinical decision-making with comprehensive visualization
*   **Clinical Impact:** Implementation of evidence-based histologic composition analysis with systematic risk stratification
*   **Target Packages:** Built-in R + `nnet`, `VGAM`
*   **Applications:** Histologic component evaluation, semi-quantitative pathology assessment, composition-based risk prediction

#### üìç **Spatial Statistics for Digital Pathology Module (spatialanalysis)**
*   **Comprehensive Spatial Analysis:** Complete implementation of spatial statistics for tabular cell coordinates from digital pathology platforms
*   **Ripley's K-Function Analysis:** Edge-corrected spatial clustering detection with L-function transformation for interpretability
*   **Nearest Neighbor Statistics:** Clark-Evans test for spatial distribution patterns with distance-based analysis
*   **Hotspot Detection:** Kernel density estimation for identifying areas of high cellular activity and biomarker expression
*   **Multi-Type Spatial Interaction:** Cross-type spatial analysis for cell-cell interaction assessment and neighborhood composition
*   **Clinical Impact:** Essential for tumor microenvironment analysis, immune cell clustering, and multiplex immunofluorescence studies
*   **Target Packages:** `spatstat`, `spatstat.geom`, `spatstat.explore`
*   **Applications:** Immune infiltration patterns, spatial biomarker analysis, tissue architecture quantification

### ‚ú® **Technical Excellence & Integration**

*   **Comprehensive Clinical Impact:** Combined modules address critical statistical gaps affecting >50% of digital pathology research studies
*   **Publication-Ready Outputs:** All modules include clinical interpretation guidelines and standardized reporting frameworks
*   **Regulatory Compliance:** Methods follow established clinical research standards and pathology guidelines
*   **Seamless Integration:** Full compatibility with existing ClinicoPath modules and jamovi ecosystem
*   **Educational Framework:** Extensive documentation with methodology explanations and best practice guidance

### üìä **Research Quality Enhancement**

*   **Statistical Rigor:** Elimination of common methodological errors through proper test selection and assumption checking
*   **Reproducible Research:** Standardized workflows reducing inter-observer variability and methodological inconsistencies
*   **Evidence-Based Medicine:** Comprehensive meta-analysis capabilities for systematic evidence synthesis
*   **Precision Medicine:** Advanced biomarker validation and machine learning deployment frameworks

### üöÄ **Advanced Survival Analysis Suite - Comprehensive Implementation**

#### **Phase 1: Core Survival Enhancements (COMPLETED)**

##### üî¨ **Cure Models for Long-term Survivors (curemodels)**
*   **Mixture Cure Models:** Complete implementation for identifying cured fraction in survival data
*   **Non-mixture Cure Models:** Alternative approach for cure fraction estimation
*   **Long-term Survivor Identification:** Statistical methods for detecting patients who will never experience the event
*   **Clinical Impact:** Essential for cancer research where a subset of patients are effectively cured
*   **Target Packages:** `smcure`, `flexsurvcure`
*   **Applications:** Oncology outcomes, treatment effectiveness evaluation

##### üè• **Multistate Survival Models (multistatesurvival)**
*   **Disease Progression Modeling:** Track patient transitions through multiple health states
*   **Transition Probability Matrices:** Calculate probabilities of moving between disease states
*   **State Occupation Probabilities:** Estimate time spent in each health state
*   **Competing Transitions:** Handle multiple possible transitions from each state
*   **Clinical Impact:** Essential for modeling complex disease pathways and treatment trajectories
*   **Target Packages:** `mstate`, `msm`
*   **Applications:** Disease progression, treatment pathways, multi-stage clinical trials

##### üìä **Relative Survival Analysis (relativesurvival)**
*   **Population-Based Comparison:** Compare observed survival to expected survival in matched population
*   **Excess Mortality Modeling:** Quantify disease-specific mortality beyond background mortality
*   **Age-Standardized Rates:** Adjust for age distribution differences in populations
*   **Cancer Registry Analysis:** Specialized methods for population-based cancer research
*   **Clinical Impact:** Gold standard for population-based cancer survival studies
*   **Target Packages:** `relsurv`, `popEpi`
*   **Applications:** Cancer registry studies, population health assessment

##### ‚úÖ **Survival Model Validation (survivalvalidation)**
*   **Prediction Error Curves:** Assess model prediction accuracy over time
*   **Time-Dependent ROC/AUC:** Evaluate discrimination ability at different time points
*   **Calibration Plots:** Visual assessment of predicted vs observed survival
*   **Cross-Validation Framework:** Robust validation using resampling methods
*   **Decision Curve Analysis:** Clinical utility assessment across risk thresholds
*   **Clinical Impact:** Essential quality assurance for survival prediction models
*   **Target Packages:** `pec`, `timeROC`, `survAUC`, `riskRegression`
*   **Applications:** Model validation, clinical decision support

##### üîó **Joint Longitudinal-Survival Models (jointmodeling)**
*   **Biomarker Trajectory Integration:** Link repeated biomarker measurements to survival outcomes
*   **Dynamic Risk Prediction:** Update survival predictions as new biomarker values become available
*   **Individual-Specific Trajectories:** Personalized prediction based on patient's biomarker evolution
*   **Time-Varying Effects:** Account for changing biomarker-survival relationships over time
*   **Clinical Impact:** Enables personalized medicine through dynamic risk assessment
*   **Target Packages:** `JMbayes2`, `joineR`, `rstanarm`
*   **Applications:** Personalized medicine, treatment monitoring, biomarker validation

##### ‚è±Ô∏è **Time-Dependent Covariates & ROC (timedependent)**
*   **Time-Varying Coefficient Models:** Handle covariates that change effects over time
*   **Landmark Analysis:** Conditional survival analysis from fixed time points
*   **Dynamic AUC Curves:** Track model discrimination ability over follow-up period
*   **Optimal Cutpoint Over Time:** Find best thresholds at different time points
*   **Clinical Impact:** Accurate modeling when predictor effects change during follow-up
*   **Target Packages:** `timeROC`, `pROC`, `survival`
*   **Applications:** Dynamic predictions, screening optimization, treatment timing

#### **Phase 5: Stage Migration Enhancements (COMPLETED)**

##### üìà **Advanced Cox Modeling (v0.0.3.81)**
*   **Frailty Models for Clustering:** Mixed-effects Cox models with center-specific random effects
*   **Multi-Institutional Data Support:** Account for heterogeneity between research centers
*   **Clinical Impact:** Proper analysis of multi-center trials and registry data

##### üìä **Enhanced Discrimination Metrics (v0.0.3.80)**
*   **Concordance Probability Estimates:** Alternative concordance measures for heavily censored data
*   **Win Ratio Analysis:** Composite endpoint analysis for staging comparison
*   **Clinical Impact:** Robust performance metrics for staging system validation

## Version 0.0.31.02

### üöÄ Major New Features

*   **OncoPathologyT Menu Group - Phase 1 Digital Pathology Validation Modules:**
    *   **New Specialized Menu Group:** Introduced OncoPathologyT for advanced oncological pathology statistical analysis
    *   **Target Audience:** Cancer researchers, digital pathology specialists, clinical pathologists, and biomarker development teams

#### üî¨ **IHC Scoring Standardization Module (ihcscoring)**
*   **H-score Calculation:** Automated histoscore computation with quality control metrics and clinical cutpoint optimization
*   **Allred Score Implementation:** Combined intensity and proportion scoring with statistical comparison capabilities
*   **Digital Validation Framework:** Algorithm vs. pathologist comparison with batch effect detection and multi-platform harmonization
*   **Agreement Analysis:** Inter-observer reproducibility assessment with ICC, correlation analysis, and Bland-Altman plots
*   **Clinical Applications:** Hormone receptor scoring (ER/PR), HER2 standardization, PD-L1 TPS assessment, Ki-67 quantification
*   **Quality Assurance:** Comprehensive scoring consistency metrics and outlier detection frameworks
*   **Publication-Ready Outputs:** Automated interpretation with clinical context and standardized reporting templates

#### üéØ **Multiplex Immunofluorescence Analysis Module (multiplexanalysis)**
*   **Co-expression Analysis:** Multi-marker correlation matrices with significance testing and pattern recognition
*   **Cell Population Phenotyping:** Unsupervised clustering with automated phenotype suggestion based on marker expression
*   **Spatial Proximity Analysis:** Cell-cell interaction statistics from coordinate data with neighborhood composition analysis
*   **Principal Component Analysis:** Dimensionality reduction with loading vectors and variance explanation for multi-parametric data
*   **Immune Contexture Scoring:** Immunoscore calculation, T-cell infiltration quantification, and immune phenotype classification
*   **Diversity Metrics:** Shannon and Simpson diversity indices for cellular composition heterogeneity assessment
*   **Clinical Applications:** Tumor microenvironment profiling, CAR-T therapy biomarkers, checkpoint inhibitor response prediction
*   **Advanced Visualization:** Correlation heatmaps, PCA biplots, clustering plots, and spatial distribution analysis

### ‚ú® **Technical Excellence Features**

*   **Comprehensive Input Validation:** Advanced error handling with descriptive feedback and data quality assessment
*   **Flexible Analysis Options:** Multiple scoring methods, customizable cutpoints, and biomarker-specific optimizations
*   **Bootstrap Confidence Intervals:** Robust statistical inference with user-configurable replication parameters
*   **Multi-Platform Compatibility:** Support for various digital pathology and imaging platforms through tabular data import
*   **Educational Framework:** Extensive clinical interpretation with methodology explanations and best practice guidelines
*   **Integration Architecture:** Seamless workflow with existing ClinicoPath modules and jamovi ecosystem

### üìä **Data Requirements and Compatibility**

*   **IHC Scoring:** Intensity scores (0-3 scale) and proportion percentages (0-100%) with optional sample identifiers
*   **Multiplex Analysis:** Multi-marker expression matrices with optional spatial coordinates (X,Y) and cell type classifications
*   **Spatial Analysis:** Coordinate-based data from image analysis platforms for proximity and clustering assessment
*   **Format Support:** CSV, Excel, and direct jamovi data input with comprehensive missing data handling

### üéØ **Clinical Impact and Applications**

*   **Standardized Methodologies:** Consistent scoring approaches across research institutions and clinical laboratories
*   **Reproducible Research:** Automated workflows reducing inter-observer variability and methodological inconsistencies
*   **Biomarker Development:** Comprehensive validation frameworks for diagnostic and prognostic marker assessment
*   **Precision Medicine:** Multi-parametric analysis supporting personalized therapy selection and treatment monitoring
*   **Regulatory Compliance:** Analysis frameworks meeting CAP guidelines and international pathology standards

### üîÆ **Roadmap Integration**

*   **Phase 1 Complete:** Digital pathology validation modules (IHC scoring, multiplex analysis)
*   **Phase 2 Next:** Spatial analysis and heterogeneity assessment modules (scheduled for implementation)
*   **Phase 3 Pipeline:** Biomarker signature development and prognostic factor analysis
*   **Phase 4 Future:** Clinical trial analytics including treatment response and adverse event analysis

## Version 0.0.31.01

### Enhancements

*   **Automatic Plot Selection (statsplot2) Module:**
    *   **Enhanced Error Messages:** Implemented comprehensive contextual error messages with variable names, data counts, and actionable guidance for debugging
    *   **Performance Optimization:** Added analysis result caching to eliminate redundant calculations between `.init()` and `.plot()` methods
    *   **Code Quality:** Extracted magic numbers to constants for better maintainability
    *   **Robust Data Validation:** Added specific validation for dotplot statistics with detailed feedback on data requirements
    *   **Edge Case Handling:** Improved validation for empty factor levels in grouped plots with informative warnings
    *   **Package Dependency Validation:** Added defensive package checking with clear installation instructions for ggalluvial and easyalluvial
    *   **Variable Type Detection:** Enhanced unknown variable type detection with warnings and class information

*   **Comprehensive jamovi Development Documentation Suite - Complete Overhaul:**
    *   **Documentation Scope:** Transformed 7 core development guides from basic introductions (~1,400 total lines) to comprehensive professional references (~12,000+ total lines) - an 850% increase in coverage
    
    *   **Analysis Options Guide (.a.yaml):** Expanded from 223 to 1,570 lines
        - Complete option type reference with 25+ option types and validation patterns
        - Advanced conditional logic, dependencies, and dynamic interfaces
        - Clinical research examples including survival analysis, biomarker studies, and clinical trials
        - Error handling patterns and user experience optimization
    
    *   **Results Definition Guide (.r.yaml):** Enhanced from 197 to 1,611 lines  
        - Comprehensive coverage of all result types: tables, plots, HTML, arrays, and outputs
        - Advanced table design patterns with clinical formatting standards
        - Dynamic result structures and conditional visibility patterns
        - Integration with statistical packages and custom formatting
    
    *   **User Interface Guide (.u.yaml):** Improved from 172 to 1,395 lines
        - Complete UI component architecture covering all jamovi interface elements
        - Clinical workflow patterns for medical research applications
        - Advanced layout strategies, conditional interfaces, and user experience design
        - Accessibility considerations and responsive design patterns
    
    *   **Table Creation Guide:** Transformed from 152 to 2,525 lines
        - Complete table development lifecycle from .r.yaml definition to .b.R population
        - Advanced formatting including clinical tables, publication-ready outputs
        - Performance optimization for large datasets and complex tables
        - Error handling and validation frameworks
    
    *   **Plot Creation Guide:** Enhanced from 156 to 1,850+ lines  
        - Comprehensive plot architecture with state management patterns
        - Advanced plot types: survival curves, forest plots, ROC curves, diagnostic plots
        - Clinical visualization applications with medical research examples
        - Theme integration, performance optimization, and troubleshooting
    
    *   **Backend Implementation Guide (.b.R):** Expanded from 197 to 2,200+ lines
        - Complete R6 class architecture and jamovi integration patterns
        - Lifecycle management with .init() and .run() comprehensive coverage
        - Advanced patterns: caching, parallel processing, memory optimization
        - Clinical applications: survival analysis, biomarker studies, trial designs
        - Testing frameworks and debugging utilities
    
    *   **Formula Construction Guide:** Enhanced from 219 to 1,800+ lines
        - Comprehensive formula patterns for statistical modeling
        - Specialized types: survival analysis, mixed effects, GAM, Bayesian models
        - Dynamic formula building and adaptive model selection
        - Clinical applications: epidemiological studies, clinical trials, biomarker analysis
        - Performance optimization and troubleshooting strategies
    
    *   **Professional Standards Implementation:**
        - Consistent documentation architecture across all guides
        - Table of contents, cross-referencing, and structured organization
        - Complete code examples with real-world ClinicoPath implementations  
        - Comprehensive error handling and troubleshooting sections
        - Best practices and coding standards throughout
    
    *   **Clinical Research Focus:**
        - Medical research workflow examples in every guide
        - Clinical trial analysis patterns and regulatory considerations
        - Biomarker analysis frameworks and diagnostic test evaluations
        - Epidemiological study designs and survival analysis applications
        - Healthcare data handling and medical terminology integration
    
    *   **Developer Experience Enhancement:**
        - Progressive complexity from basic to advanced implementations
        - Real debugging scenarios with step-by-step solutions  
        - Performance benchmarking and optimization strategies
        - Code quality standards and testing frameworks
        - Integration patterns with clinical research packages

*   **Advanced Digital Pathology Analysis Suite - New Implementation:**
    *   **Comprehensive Module Suite:** 4 new specialized modules for digital pathology validation and analysis
    
    *   **Enhanced Agreement Statistics (pathologyagreement):** 
        - Inter-platform reproducibility analysis (HALO vs Aiforia vs ImageJ)
        - Multiple agreement metrics: ICC(3,1), Concordance Correlation Coefficient, Spearman correlation
        - Bootstrap confidence intervals with 1000 replicates for robust estimation
        - Bland-Altman plots with bias assessment and clinical interpretation
        - Implementation follows Zilenaite-Petrulaitiene et al. (Am J Clin Pathol 2025) methodology
    
    *   **Digital Pathology Validation Workflow (digitalvalidation):**
        - FDA/CE-IVD algorithm validation framework for clinical deployment
        - Comprehensive analytical performance assessment (accuracy, precision, linearity)
        - Clinical decision impact analysis with threshold-based classification
        - Bias detection (systematic and proportional) with statistical testing
        - Regulatory compliance assessment following CAP/CLSI EP09 guidelines
        - Train-test validation with Harrell's C-index and likelihood ratio tests
    
    *   **Biopsy Simulation Analysis (biopsysimulation):**
        - Core needle biopsy adequacy assessment and optimization
        - Sampling variability quantification using coefficient of variation analysis
        - Variance component decomposition (between-case vs within-case vs method variance)
        - Reproducibility assessment across multiple simulated biopsy samples
        - Clinical recommendations for optimal sampling strategies
        - Implementation based on hexagonal grid subsampling methodology
    
    *   **Haralick Texture Analysis (haralicktexture):**
        - Complete Haralick feature analysis (entropy, contrast, correlation, energy, homogeneity)
        - Spatial heterogeneity quantification for tumor microenvironment characterization
        - Distribution analysis with normality testing and skewness/kurtosis assessment
        - Inter-feature correlation analysis with redundancy detection
        - Prognostic biomarker development framework
        - Clinical interpretation guides for Ki67, HER2, PD-L1, and CD8+ analyses
    
    *   **Professional Standards Implementation:**
        - Explanatory text throughout all functions to guide researchers
        - Clinical interpretation frameworks with actionable recommendations  
        - Regulatory compliance indicators for FDA/CE submission readiness
        - Bootstrap confidence intervals and robust statistical methods
        - Comprehensive error handling with informative user guidance
        - Integration with survival analysis and prognostic modeling workflows

## Version 0.0.3.96

### New Features & Enhancements

*   **Waterfall Plot Module:**
    *   Implemented group-based coloring for waterfall and spider plots.
    *   Added `colorBy`, `spiderColorBy`, and `spiderColorScheme` options for customization.
    *   Refactored code for quality and performance improvements.
    *   Improved data validation with user-friendly messages.
*   **IHC Expression Analysis Module:**
    *   Fixed issues with the `clear()` method, improving table population reliability.
*   **Medical Decision Tree Analysis:**
    *   Added a progress bar for real-time feedback.
    *   Fixed several runtime errors and improved parameter validation.

## Version 0.0.3.95

### Bug Fixes

*   **Tree Module:**
    *   Resolved critical syntax errors that were preventing module compilation.
    *   Restored the `.train_model` function.
    *   Fixed variable initialization and scoping issues.
*   **Decision Analysis Framework:**
    *   Enhanced the `decisiongraph` module with health economics features.
    *   Added Net Monetary Benefit (NMB) and Incremental Cost-Effectiveness Ratio (ICER) analysis.

## Version 0.0.3.90

### Documentation

*   Updated all submodule documentation links in the `README` to point to their respective documentation sites.

## Version 0.0.3.82

### New Features

*   **Clinical Utility Index:**
    *   Implemented a comprehensive framework for assessing the clinical utility of staging systems.
    *   Added Net Benefit Analysis and Number Needed to Treat (NNT) calculations.

## Version 0.0.3.81

### New Features

*   **Frailty Models:**
    *   Added support for frailty models for clustered survival data using mixed-effects Cox models.

## Version 0.0.3.80

### New Features

*   **Concordance Probability Estimates:**
    *   Added advanced concordance probability analysis for heavily censored data.
*   **Win Ratio Analysis:**
    *   Implemented win ratio analysis for composite endpoint evaluation.